InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
85.37
(
0.30%
)
Bitcoin
63,390.72
(
1.15%
)
Post# of 252444
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: DewDiligence post# 123325

Thursday, 07/14/2011 8:51:11 PM

Thursday, July 14, 2011 8:51:11 PM

Post# of 252444
Medivir @ Jefferies (6/8/11)

http://www.medivir.se/v4/images/pdf/2011/Jefferies_Healthcare_Conference_June_2011.pdf

Some key points:

1. Slide 8 - 115,000 chronic HCV patients in the Nordics; 3,000 receive treatment per year.
2. Slide 16 - Analysts estimate peak sales of TMC435 as $2-$4B dollars
3. Slide 18 - They also have an NS5A program at LO stage (assume that's lead optimization) along with other nukes
4. Slide 20 - TMC435 patent life extends to 2026 and 2028
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up